HistoSonics gets Taiwan approval for its tumour-destroying ultrasound system as it pushes into Asia
HistoSonics has received regulatory approval from Taiwan’s Food and Drug Administration for its Edison Histotripsy System, a non-invasive cancer treatment device that uses focused ultrasound